Delivery Order SPE2DB24D1021-SPE2DB25FEWPV

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,972.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Terbinafine HCl 250 mg tablets, a medication used to treat fungal infections. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 6, 2025. This award is not associated with a set-aside program, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,163.16, is a Delivery Order for 4,566,761,020 units of Terbinafine HCL 250 mg tablets with a completion date of December 19, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award SPE2DB22D1017|SPE2DB25FG0JZ was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,949,076 units of Terbinafine HCL 250 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,982.21 and an ultimate completion date of April 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This federal contract award, valued at $7,360.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of terbinafine hydrochloride 250 mg tablets, a medication used to treat fungal infections. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is for the delivery of Terbinafine Hydrochloride 250 mg Tablets in quantities of 30 tablets per package. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,898.46 and an ultimate completion date of November 25, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVL96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,837.26 firm fixed-price delivery order is for the supply of 4,568,078,153 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 29, 2025. This award is not designated as a set-aside contract....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,076 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $7,977.54 and a period of performance through April 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,322.78 firm fixed-price delivery order is for the supply of 4,567,421,522 units of terbinafine HCL 250 mg tablets. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of terbinafine hydrochloride 250 mg tablets, with a ceiling value of $5,970.95. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type, with a period of performance through February 5, 2025. The contract does not have a set-aside designation, indicating it was awarded through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,567,331,964 units of the generic drug Terbinafine Hydrochloride 250 mg tablets. The contract has a firm fixed price of $2,265.84 and a completion date of February 21, 2025. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEWPV
    Delivery Order

This federal contract award, valued at $5,556.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,175,171 units of the medication terbinafine HCL 250 mg tablets, with a completion date of May 8, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle for the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026. The contract is not set aside and was competitively awarded.

Generated 8/6/25, 9:58 AM